SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318306-00-000003
Filing Date
2000-03-30
Accepted
2000-03-30 00:00:00
Documents
8
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 195292
2 EMPLOYMENT AGREEMENT OF DAVID P. NOWOTNIK, PH.D. EX-10.19 24584
3 401(K) PLAN EX-10.20 58217
4 SUBSIDIARIES OF THE REGISTRANT EX-21 162
5 CONSENT OF GRANT THORNTON LLP EX-23.1 612
6 CONSENT OF KPMG LLP EX-23.2 1751
7 CONSENT OF SMITH ANGLIN & CO. EX-23.3 652
8 FDS EX-27 1686
  Complete submission text file 0000318306-00-000003.txt   285297
Mailing Address 2600 N STEMMONS FRWY STE 210 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 587427
SIC: 2834 Pharmaceutical Preparations